Apogee Therapeutics Știri Eulerpool

Apogee Therapeutics Eulerpool News

Apogee Therapeutics Știri Acțiune

Apogee Therapeutics este urmărit de numeroși jurnaliști și investitori din întreaga lume. Cele mai recente Apogee Therapeutics știri le adunăm aici.

• 18 iunie ·

  SeekingAlpha
  Apogee Therapeutics: Infrequent Dosing Advantage In Biotech Play
• 6 iunie ·

  Thefly.com
  Apogee Therapeutics intiated with Not Rated at Goldman Sachs
• 31 mai ·

  TipRanks
  Buy Rating for Apogee Therapeutics: Promising Prospects for Dupixent and APG808 in COPD Market
• 28 mai ·

  Yahoo
  Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
• 28 mai ·

  TipRanks
  Apogee Therapeutics Welcomes Dr. Bollinger to Board
• 28 mai ·

  Thefly.com
  Apogee Therapeutics expands board of directors with appointment of Bollinger
• 27 mai ·

  Yahoo
  Here's Why We're Not Too Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Situation
• 25 mai ·

  Seeking Alpha
  Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
• 23 mai ·

  Yahoo
  Apogee Therapeutics to Participate in Upcoming June Investor Conferences
• 15 mai ·

  Yahoo
  Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases